In 2023, the trade exchange (includes international purchases and sales) of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds was US$380M.
In 2023, the states with the most international sales in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were Ciudad de México (US$52.8M), Nuevo León (US$35.2M), Estado de México (US$20.3M), Morelos (US$11.7M), and Querétaro (US$5.4M).
The states with the most international purchases in 2023 were Ciudad de México (US$77.4M), Estado de México (US$54.6M), Coahuila de Zaragoza (US$54M), Nuevo León (US$21.4M), and Jalisco (US$16.1M).
In 2023, the main commercial destinations of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$37.5M), India (US$18.1M), Brazil (US$11.8M), Canada (US$6.67M), and Spain (US$6.61M).
The main commercial origins of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in 2023 were China (US$133M), India (US$39.5M), Germany (US$12.2M), Switzerland (US$12.2M), and Singapore (US$12M).
In the global context, the main exporting countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in 2022 were Ireland (US$9B), China (US$5.81B), and Switzerland (US$3.47B). In the same year, the main importing countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$11.2B), Germany (US$3B), and Canada (US$1.64B).